Introduction
Komodo Health is a San Francisco company co-founded in 2014 by Arif Nathoo, MD, and Web Sun that builds healthcare intelligence from large-scale de-identified patient journey data. Nathoo serves as co-chief executive officer alongside Sun as of June 2026 leadership disclosures on Komodo’s press page — reflecting an evolved executive structure with Miles Ennis as president. Komodo markets itself as a vertical AI company: AI trained on healthcare-specific data foundations rather than general-purpose models bolted onto claims extracts.
On August 20, 2025, Komodo launched Marmot, described as the first healthcare-native AI engine for discovery, development, and delivery of patient care, built on the Healthcare Map covering more than 330 million de-identified patient journeys per subsequent partner announcements.
Komodo’s June 25, 2026 Alnylam expansion press release quotes Nathoo describing Marmot as a new operating model — not merely a productivity tool — signaling how enterprise pharma buyers frame analytics AI procurement in 2026.
Supporting leadership sourced from komodohealth.com/company/ after /leadership returned 404 at review.
What the company does
Komodo’s Healthcare Map links medical and pharmacy claims, encounters, and related data into longitudinal patient journeys used for real-world evidence, market analytics, and AI agent workflows. Marmot generates transparent analytics in minutes — Komodo’s positioning against static dashboards and siloed reporting. June 25, 2026, Komodo announced expanded deployment of Marmot at Alnylam Pharmaceuticals across enterprise functions beyond an initial commercial AI agent pilot, illustrating pharma enterprise adoption.
Marmot launched August 20, 2025 as a healthcare-native AI engine — Komodo’s bet that vertical models trained on curated map data outperform general LLMs asked to reason over ad hoc claims extracts uploaded per project.
Who it serves
Komodo serves life sciences commercial and medical affairs teams, health economics researchers, payers analyzing population trends, and provider organizations evaluating referral patterns. Alnylam — an RNAi therapeutics company — is a named enterprise customer scaling Marmot in Komodo’s June 2026 release. Buyers care about data provenance, reproducibility, and HIPAA-compliant de-identification because analytics errors in pharma strategy are expensive to unwind.
Alnylam initially adopted Marmot for commercial AI agents before expanding enterprise-wide per the June 2026 release — a land-and-expand pattern Komodo cites when selling analytics AI to pharmas evaluating pilot-to-platform transitions.
Company background
Nathoo and Sun started Komodo in late 2014, naming the company after the Komodo dragon as a reminder of the scale of their healthcare data ambition, per Komodo perspective articles. Nathoo, a Harvard-educated physician and former McKinsey consultant, oversees data science and product development per the company page. Komodo has expanded through Marmot’s 2025 launch and 2026 leadership changes elevating commercial execution under President Miles Ennis.
Web Sun joined Nathoo as co-founder with pharma and consulting experience cited in Komodo company materials; the June 2026 leadership evolution made Sun co-CEO alongside Nathoo while Ennis took president responsibilities — a structure reflecting scale complexity as Marmot moves from launch to enterprise deployments.
Founded 2014 in San Francisco per company materials reviewed July 10, 2026.
Product and AI capabilities
Marmot applies large language models and specialized healthcare analytics agents to Komodo’s curated map — generating analyses with audit trails and reproducibility Komodo emphasizes for regulated enterprise buyers. AWS Marketplace and Snowflake Marketplace availability announcements on Komodo’s press page show distribution strategy: embed healthcare intelligence where pharma data teams already work. This differs from hospital ambient AI — Komodo sells to enterprises analyzing populations, not documenting individual visits.
June 2026 Marmot capability releases on Komodo’s press page target reproducibility and enterprise-wide adoption — features aimed at consultants, analysts, and executives who previously relied on disconnected dashboard exports refreshed quarterly.
Key developments
2014: Komodo Health founded by Arif Nathoo and Web Sun. August 20, 2025: Marmot platform launched. June 16, 2026: Leadership evolution — Ennis president, Sun co-CEO with Nathoo. June 25, 2026: Alnylam expands Marmot enterprise partnership. Komodo cites Healthcare Map covering 330+ million de-identified patient journeys in partner releases.
Why it matters
Komodo matters because real-world data vendors are racing to become AI operating layers — not quarterly report vendors. Marmot’s Alnylam expansion is evidence that a top-20 biotech treats Komodo as infrastructure. Compare with Innovaccer population-health activation for providers and Owkin federated hospital networks for discovery — complementary data architectures serving different buyers.
Healthcare Map scale — more than 330 million de-identified patient journeys cited in Komodo partner releases — is the moat argument Marmot makes against general-purpose LLMs fine-tuned on small customer uploads.
Sector context
Komodo Health belongs in Brel’s AI in healthcare coverage under healthcare analytics and real-world evidence, related to Innovaccer and life-sciences AI from Owkin. Clinical AI vendors such as Qure.ai operate at imaging read time, not population-scale claims analytics.
Marmot’s August 2025 launch webinar featured co-founders Nathoo and Sun per Komodo press materials — public executive visibility that continued through June 2026 Alnylam and leadership-evolution announcements.
Reviewed 2026-07-10. Confidence High.
Sources and references
Komodo Marmot launch press release (August 20, 2025), company leadership page, and Alnylam partnership release (June 25, 2026).
- Komodo — Marmot launch (komodohealth.com, August 20, 2025)
- Komodo — Company page (komodohealth.com)
- Komodo — Alnylam partnership (komodohealth.com, June 25, 2026)
Reviewed July 10, 2026. Arif Nathoo, MD, is co-founder and co-CEO per company page. Founded 2014 in San Francisco. Confidence: High.